Benzodiazepines versus placebo for panic disorder in adults

To assess the effects of benzodiazepines (BDZs) for panic disorder in adults, specifically:

  1. To determine the efficacy of BDZs in alleviating symptoms of panic disorder with or without agoraphobia in comparison to placebo;
  2. To review the acceptability of BDZs in panic disorder with or without agoraphobia in comparison with placebo; and
  3. To investigate the adverse effects of BDZs in panic disorder with or without agoraphobia, including the general prevalence of adverse effects, compared to placebo.

This is a protocol.

Share/Save